Ashish Sharma

As toxinas s o geralmente consideradas agentes nocivos; no entanto, podem ser muito teis na terapia de doen as humanas. A neurotoxina botul nica (BTX) foi a primeira prote na microbiana a ser administrada por inje o a ser usada terapeuticamente em humanos. A BTX apareceu como um dos agentes terap uticos mais polivalentes da medicina moderna com mais aplica es cl nicas do que qualquer outro atualmente no mercado. Com uma melhor compreens o dos mecanismos celulares da neurotoxina botulinun e os avan os da biotecnologia, os futuros produtos de neurotoxinas botulinun provavelmente ser o ainda mais eficazes e personalizados s indica es espec ficas e adaptados s necessidades dos pacientes. A sua crescente implementa o, sob v rias circunst ncias, torna-o o medicamento mais vers til do mercado, abrangendo quase todas as especialidades m dicas. Embora considerado eficiente e seguro, ainda existem muitas restri es, tais como o desconforto relacionado inje o, a dura o relativamente curta da rea o, a chance de imunogenicidade e alta.

Les toxines sont g n ralement consid r es comme des agents nuisibles; cependant, elles peuvent tre tr s utiles dans le traitement de maladies humaines. La neurotoxine botulique (BTX) a t la premi re prot ine microbienne tre administr e par injection pour tre utilis e des fins th rapeutiques chez l'homme. La BTX est apparue comme l'un des agents th rapeutiques les plus polyvalents de la m decine moderne, avec plus d'applications cliniques que tout autre agent actuellement sur le march . Avec une meilleure compr hension des m canismes cellulaires de la neurotoxine botulinique et les progr s de la biotechnologie, les futurs produits base de neurotoxine botulinique seront probablement encore plus efficaces et adapt s aux indications sp cifiques et aux besoins des patients. Sa mise en oeuvre croissante, dans diverses circonstances, en fait le m dicament le plus polyvalent du march , couvrant presque toutes les sp cialit s m dicales. Bien qu'il soit consid r comme efficace et s r, de nombreuses contraintes subsistent, telles que l'inconfort li l'injection, la dur e relativement br ve de la r action, le risque d'immunog nicit , et un niveau lev .

Le tossine sono solitamente considerate agenti dannosi; tuttavia, possono essere molto utili nella terapia delle malattie umane. La neurotossina botulinica (BTX) stata la prima proteina microbica ad essere somministrata per iniezione per essere usata terapeuticamente nell'uomo. BTX apparso come uno degli agenti terapeutici pi polivalenti nella medicina moderna con pi applicazioni cliniche di qualsiasi altro attualmente sul mercato. Con una migliore comprensione dei meccanismi cellulari della neurotossina botulinica e i progressi della biotecnologia, i futuri prodotti della neurotossina botulinica saranno probabilmente ancora pi efficaci e personalizzati in base alle indicazioni specifiche e alle esigenze dei pazienti. La sua crescente applicazione, in varie circostanze, lo rende il farmaco pi versatile sul mercato, che abbraccia quasi tutte le specialit mediche. Anche se ritenuto efficiente e sicuro, ci sono ancora molti vincoli, come il disagio legato all'iniezione, la durata relativamente breve della reazione, la possibilit di immunogenicit , e alta.

Toxine werden in der Regel als sch dliche Agenzien betrachtet; sie k nnen jedoch bei der Therapie menschlicher Erkrankungen sehr hilfreich sein. Botulinum Neurotoxin (BTX) war das erste mikrobielle Protein, das durch Injektion verabreicht wurde, um therapeutisch beim Menschen eingesetzt zu werden. BTX hat sich als eines der vielseitigsten therapeutischen Mittel in der modernen Medizin mit mehr klinischen Anwendungen als jedes andere derzeit auf dem Markt befindliche Mittel erwiesen. Mit einem besseren Verst ndnis der zellul ren Mechanismen von Botulinun-Neurotoxin und den Fortschritten in der Biotechnologie werden zuk nftige Botulinun-Neurotoxin-Produkte wahrscheinlich noch effektiver und auf die spezifischen Indikationen und Bed rfnisse der Patienten zugeschnitten sein. Seine zunehmende Anwendung unter verschiedenen Umst nden macht es zum vielseitigsten Medikament auf dem Markt, das fast alle medizinischen Fachgebiete abdeckt. Obwohl es als effizient und sicher gilt, gibt es immer noch viele Einschr nkungen, wie z. B. injektionsbedingte Unannehmlichkeiten, vergleichsweise kurze Dauer der Reaktion, die M glichkeit der Immunogenit t und hoch.

Toksyny są zwykle uważane za czynniki szkodliwe, jednak mogą byc bardzo pomocne w terapii chor b czlowieka. Neurotoksyna botulinowa (BTX) byla pierwszym bialkiem bakteryjnym podawanym we wstrzyknięciach i stosowanym terapeutycznie u ludzi. BTX okazal się jednym z najbardziej uniwersalnych środk w terapeutycznych we wsp lczesnej medycynie, mającym więcej zastosowań klinicznych niż jakikolwiek inny dostępny obecnie na rynku. Dzięki lepszemu zrozumieniu mechanizm w kom rkowych dzialania neurotoksyny botulinowej oraz postępom biotechnologii, przyszle produkty z neurotoksyną botulinową będą prawdopodobnie jeszcze bardziej skuteczne i dostosowane do konkretnych wskazań oraz potrzeb pacjent w. Jej coraz szersze zastosowanie, w r żnych okolicznościach, czyni ją najbardziej uniwersalnym lekiem na rynku, obejmującym niemal wszystkie specjalności medyczne. Mimo, że uważany jest za skuteczny i bezpieczny, nadal ma wiele ograniczeń, takich jak dyskomfort związany z iniekcją, stosunkowo kr tki czas trwania reakcji, możliwośc immunogenności i wysoki.

The development of bioactive surgical additives to regulate the inflammation and increase the speed of healing process is one of the great challenges in clinical research. In this sense, platelet rich fibrin (PRF) appears as a natural and satisfactory alternative with favourable results and low risks. The following is to summarize the relevant literature regarding the technique of using PRF, focusing on its preparation, advantages, and disadvantages of using it in clinical applications. PRF alone or in combination with other biomaterials seems to have several advantages and indications both for medicine and dentistry, due it is a minimally invasive technique with low risks and satisfactory clinical results.

Toxins are usually considered to be damaging agents; however, they may be very helpful in the therapy of human illness. Botulinum neurotoxin (BTX) was the first microbial protein to be administered by injection to be used therapeutically in humans. BTX has appeared as one of the most multipurpose therapeutic agents in modern medicine with more clinical apps than any other presently on the market. With a better understanding of the cellular mechanisms of botulinun neurotoxin and the advances in biotechnology, future botulinun neurotoxin products are likely to be even more effective and customized to the specific indications and tailored to the needs of patients. Its increasing implementation, under various circumstances, makes it the most versatile drug on the market, spanning almost all medical specialties. Although deemed efficient and secure, there are still many constraints, such as injection-related discomfort, comparatively brief length of reaction, the chance of immunogenicity, and high.

Intended for practising rheumatologists, this book will also be useful for postgraduate students and internists with an interest in rheumatology. It familiarises clinicians involved in the care of patients with spondyloarthritis (SpA) with various common and uncommon imaging features of these disorders. In addition, it will serve as a reference for comparison of imaging features observed by clinicians in their day-to-day practice. The purpose is to make it easier for a rheumatologist to understand the report given by a radiologist in this context and to participate with a basic understanding during multidisciplinary meetings involving radiology colleagues. The aim is to ensure better patient care through shared understanding of imaging findings. Detailed illustrations and explanation of various imaging findings in patients with spondyloarthritis. Basic science of MRI and its sequences have been explained in a simple language which rheumatologists and internists can understand. Various uncommon imaging features like entheseal inflammation and ligamentous ossification have been nicely illustrated. Provides a vivid collection of plain radiographs, MRIs and CT scans obtained during care of patients with spondyloarthritis. Both the axial and peripheral joints have been included.

What is the one quality we all share? We are all narrators. Each of us has many stories to tell; good ones, bad ones, romantic ones, etc. Mr Amar Singh is a man with many problems. He has less income, more responsibilities and very less reputation, but this does not define him. Only one word can define him. He is a NARRATOR. On the other hand, there is Shri Satya Prakash Dubey, who has money, name and fame. However, he has a dark past and an uncertain future. He is the protagonist in the story told by Mr Amar Singh, which has colourful characters, who at times represent the grey shades of humanity. The Narrator travels between the meaninglessness of life to the meaningfulness of life. Just turn a few pages, and you will know how.